# Odronextamab in Low Tumor Volume Advanced FL

> **NCT07128641** · PHASE2 · RECRUITING · sponsor: **Gottfried von Keudell, MD PhD** · enrollment: 35 (estimated)

## Conditions studied

- Follicular Lymphoma
- Lymphoma

## Interventions

- **BIOLOGICAL:** Odronextamab

## Key facts

- **NCT ID:** NCT07128641
- **Lead sponsor:** Gottfried von Keudell, MD PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-08
- **Primary completion:** 2027-01-02
- **Final completion:** 2028-01-02
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07128641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07128641, "Odronextamab in Low Tumor Volume Advanced FL". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07128641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*